SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (10886)7/22/1999 11:16:00 PM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
You asked>>>>>>>>What do you think of Allergan as a way to play BPI? Strange that the FDA advisory board did not explain why they turned down Allergan's drug.<<<<
Good question but I have much more to go on in possibilities of BPI panning out in blood borne infections not eyeball topical. Now if they had a Baboon eyeball study published and Phase I/II equivalent like in Meningo....